![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07C 237/22 | |
A61K 31/166 | |||
A61P 29/00 |
(11) | Number of the document | 2870137 |
(13) | Kind of document | T |
(96) | European patent application number | 13737357.7 |
Date of filing the European patent application | 2013-07-05 | |
(97) | Date of publication of the European application | 2015-05-13 |
(45) | Date of publication and mention of the grant of the patent | 2018-05-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2013/051781 |
Date | 2013-07-05 |
(87) | Number | WO 2014/006414 |
Date | 2014-01-09 |
(30) | Number | Date | Country code |
201261668543 P | 2012-07-06 | US | |
201212081 | 2012-07-06 | GB |
(72) |
NORTHEN, Julian Scott, GB
MYKYTIUK, John, GB
|
(73) |
Kalvista Pharmaceuticals Limited,
Porton Science Park Incubator Centre Bybrook Road, Porton Down Wiltshire SP4 0BF,
GB
|
(54) | POLYMORPHS OF N-[(R)-1-[(S)-1-(4-AMINOMETHYL-BENZYLCARBAMOYL)-2-PHENYL-ETHYLCARBAMOYL]-2-(4-ETHOXY-PHENYL)-ETHYL]-BENZAMIDE HYDROCHLORIDE |
POLYMORPHS OF N-[(R)-1-[(S)-1-(4-AMINOMETHYL-BENZYLCARBAMOYL)-2-PHENYL-ETHYLCARBAMOYL]-2-(4-ETHOXY-PHENYL)-ETHYL]-BENZAMIDE HYDROCHLORIDE |